Results 51 to 60 of about 5,332,530 (372)

Attitude to Secondary Prevention and Concerns about Colonoscopy Are Independent Predictors of Acceptance of Screening Colonoscopy [PDF]

, 2010
Background: Colonoscopy in combination with endoscopic polypectomy has been shown to be an efficient measure for reducing colorectal cancer incidence.
Bühner, Markus, Kolligs, Frank Thomas, Schubring-Giese, Bodo, Ziegler, Matthias   +3 more
core   +1 more source

Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population [PDF]

, 2006
Background Bowel cancer is common and is a major cause of death. Meta-analysis of randomised controlled trials estimates that screening for colorectal cancer using faecal occult blood (FOB) test reduces mortality from colorectal cancer by 16%.
Colbourne, Lynne, Dunn, Janet A, Hobbs, Richard FD, Ismail, Tariq, Martin, Ashley, Patrick, Fiona, Redman, Val D, Ryan, Angela V, Wakelam, Michael JO, Wilson, Sue   +9 more
core   +2 more sources

Partial Versus Total Mesorectal Excision for the Surgical Treatment of Mid-Rectal Cancer: An Assessment from the Turkish Society of Colon and Rectal Surgery’s Colorectal Cancer Database

Turkish Journal of Colorectal Disease
Aim: Although total mesorectal excision (TME) is standard, partial mesorectal excision (PME) is increasingly performed in upper rectal cancer to preserve a longer rectal stump, potentially improving outcomes.
Volkan Özben, Nuri Okkabaz, Turkish Colorectal Cancer Database Study Group   +2 more
doaj   +1 more source

Supplementing factual information with patient narratives in the cancer screening context: a qualitative study of acceptability and preferences [PDF]

, 2015
Objective To explore people's responses to narrative information in the context of colorectal cancer screening. Design nineteen in-depth interviews were conducted with men and women (aged 45–59).
Bandura, Banks-Wallace, Bekker, Dillard, Entwistle, Epstein, Erwin, Hinyard, Hwang, Kahneman, Khangura, Kreuter, Kreuter, Lemal, McQueen, McQueen, Michielutte, Ritchie, Rothman, Shaffer, Slovic, Winterbottom, Wise, Wit   +23 more
core   +1 more source

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

New England Journal of Medicine, 2004
BACKGROUND The epidermal growth factor receptor (EGFR), which participates in signaling pathways that are deregulated in cancer cells, commonly appears on colorectal-cancer cells. Cetuximab is a monoclonal antibody that specifically blocks the EGFR.
D. Cunningham, Y. Humblet, S. Siena, D. Khayat, H. Bleiberg, A. Santoro, D. Bets, M. Mueser, A. Harstrick, C. Verslype, I. Chau, E. Van Cutsem   +11 more
semanticscholar   +1 more source

A Rare Complication After Laparoscopic Lateral Lymph Node Dissection for Rectal Cancer: Two Case Reports of Internal Hernia Below the Superior Vesical Artery

Journal of the Anus, Rectum and Colon, 2018
Total mesorectal excision or mesorectal excision with lateral lymph node dissection (LLND) is a standard treatment for locally advanced lower rectal cancer in Japan.
Daichi Kitaguchi, Yuji Nishizawa, Takeshi Sasaki, Yuichiro Tsukada, Akihiro Kondo, Hiro Hasegawa, Masaaki Ito   +6 more
doaj   +1 more source

Radiotherapy and Chemotherapy for Colorectal Cancer [Abridged] [PDF]

, 1973
J P Bottomley, E.H. Cooper
  +6 more sources

Regorafenib Plus Nivolumab in Patients With Advanced Gastric or Colorectal Cancer: An Open-Label, Dose-Escalation, and Dose-Expansion Phase Ib Trial (REGONIVO, EPOC1603).

Journal of Clinical Oncology, 2020
PURPOSE This is a phase Ib trial of regorafenib plus nivolumab for gastric and colorectal cancer. PATIENTS AND METHODS Enrolled patients received regorafenib plus nivolumab in a dose-finding part to estimate the maximum tolerated dose.
S. Fukuoka, H. Hara, N. Takahashi, T. Kojima, A. Kawazoe, M. Asayama, T. Yoshii, D. Kotani, H. Tamura, Y. Mikamoto, N. Hirano, M. Wakabayashi, S. Nomura, A. Sato, T. Kuwata, Y. Togashi, H. Nishikawa, K. Shitara   +17 more
semanticscholar   +1 more source

Prognostic nomograms for predicting cause-specific survival and overall survival of stage I–III colon cancer patients: a large population-based study

Cancer Cell International, 2019
Background The purpose of this study was to build functional nomograms based on significant clinicopathological features to predict cause-specific survival (CSS) and overall survival (OS) in patients with stage I–III colon cancer.
Zheng Zhou, Shaobo Mo, Weixing Dai, Wenqiang Xiang, Lingyu Han, Qingguo Li, Renjie Wang, Lu Liu, Long Zhang, Sanjun Cai, Guoxiang Cai   +10 more
doaj   +1 more source

A cohort study of the recovery of health and wellbeing following colorectal cancer (CREW study): protocol paper [PDF]

, 2012
Background: the number of people surviving colorectal cancer has doubled in recent years. While much of the literature suggests that most people return to near pre-diagnosis status following surgery for colorectal cancer, this literature has largely ...
Addington-Hall, Julia M., Corner, Jessica L, Fenlon, Deborah R., Foster, Claire L., Richardson, Alison, Smith, Peter, Winter, Jane   +6 more
core   +2 more sources